HIV/AIDS News & Information

Speaker: Robert M. Califf, MD, Professor of Medicine, Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Baseline data from the Falsartan in cute Myocardial infarction Trial (VALIANT) demonstrated that the early use of beta blockade in patients with an acute myocardial infarction (AMI), complicated by heart failure and/or left ventricular systolic [...]

Speaker: David E. Allie, MD, Director of Cardiothoracic and Vascular Surgery, Cardiovascular Institute of the South, Lafayette, Louisiana.
Bivalirudin (Angiomax®, The Medicines Company), a novel direct thrombin inhibitor, has been shown to be safe and feasible as the sole anticoagulant in patients undergoing renal and iliac percutaneous peripheral interventions (PPIs) for peripheral vascular disease.

Speaker: Rosario A. Mercado-Young, MD, Fellow in Cardiology, University of Texas Health Science Center, San Antonio, Texas.
An extended-release niacin formulation (Niaspan®, Kos) has been found to be safe, well tolerated, and effective in a wide range of patients with dyslipidemia, including those with diabetes.

Drug-Eluting Stents for Coronary Artery Lesions
Speaker: Antonio Colombo, MD, Professor of Medicine, EMO Centre Cuone Columbus Hospital, Milan, Italy.
A 12-month follow-up of the paclitaxel stent (Taxus™, Boston Scientific) study (TAXUS II) demonstrated that paclitaxel-elut-ing coronary stents were highly effective at one year after implantation with sustained benefits, as measured by decreased rates of major adverse [...]

Estrogen and Language Processing
Speakers: Guinevere Eden, DPhil, and Ivy Estabrooke, both of Georgetown University
New research from Georgetown University in Washington DC, and the National Institute of Aging has found that estrogen can influence the speed and accuracy of language processing in healthy young women, perhaps by affecting the brain mechanisms that are used to form [...]

A record number of researchers and exhibitors—more than 28,800—attended the 33rd annual meeting of the Society for Neuroscience (SFN), held November 8-12 in New Orleans. The SFN annual meeting is considered to be the premier venue for neuroscientists to meet and exchange information related to the latest discoveries about the brain, spinal cord, and nervous [...]

A substantial risk of relapse is associated with the discontinuation of antidepressant therapy after the acute symptoms of a depressive episode resolve. It is widely recognized that an additional four to six months of continued treatment is needed to consolidate patient response and to prevent relapse. Rapaport et al. conducted a multicenter trial to determine [...]